European Pharmaceutical Review

APRIL 20, 2023

“These results are exciting… this treatment led to fewer days with migraine for people who had already tried up to four other types of drugs to prevent migraine and either had no improvement or had side effects that outweighed any benefits,” commented study author Dr Patricia Pozo-Rosich, PhD at Vall d’Hebron University Hospital in Barcelona, Spain.

Side effects 98

Side effects Safety Medical Pharmaceutical 98

European Pharmaceutical Review

OCTOBER 10, 2022

percent of whooping cough cases in 2021 were those six months or younger. Side effect data related to those given the non-US variation during pregnancy was consistent with data for individuals who were given the non-US formulation post labour. The US Centres for Disease Control and Prevention (CDC) estimate that 4.2

FDA 105

FDA Food and Drug Administration Side effects Food 105

European Pharmaceutical Review

NOVEMBER 1, 2023

The most common side effects with Nuvaxovid XBB.1.5 Nuvaxovid was first authorised in the European Union in December 2021. Based on these data, the Committee concluded that Nuvaxovid XBB.1.5 is expected to trigger an adequate immune response against XBB.1.5. Adapted versions of Nuvaxovid targeting the Omicron variant BA.5

Side effects 105

Side effects Medicine Safety Marketing 105

Pharmaceutical Technology

NOVEMBER 14, 2022

Such developments, including a 2021 approval of AstraZeneca’s Saphnelo (anifrolumab) , prompted The Lancet Rheumatology to posit that 2022 could be a “banner year” for the condition. In the five-patient report, mild cytokine release syndrome, a common side effect with CAR-Ts was observed, but the treatment was considered well tolerated.

Side effects 144

Side effects Patients Manufacturing Safety 144

European Pharmaceutical Review

OCTOBER 7, 2022

This is especially beneficial as a way of decreasing potential side effects. Tablets were noted to be the most common form of OSD in 2021 because of their convenience and simplicity in production, transportation and delivery to the end user. The research saw that a demand for bilayer tablets specifically, is on the rise.

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

pharmaphorum

NOVEMBER 16, 2022

Cases of drug-resistant TB (DR-TB) rose 3% in 2021 over the previous year, the first increase since record-keeping started in 2004, according to the WHO report, which called for countries to move quickly to restore access to essential services to treat the disease, as well as greater investment in new vaccines and therapeutics.

Side effects 95

Side effects Healthcare Healthcare Patients 95

World of DTC Marketing

DECEMBER 28, 2020

As we look forward to 2021 DTC marketers should be noting the changes in consumer attitudes and the way they request new treatments. HCP’s want to ensure they are aware of the risks and possible side effects of new therapies. Much has changed but a lot is also the same. Some are, but most aren’t.

Doctors 296

Doctors Side effects Marketing Patients 296

Pharmaceutical Technology

MAY 25, 2023

The trial, conducted in 1,800 healthy individuals ranging from ages 2-29 years in Mali and The Gambia in 2021, found NmCV-5 induced a strong immune response across five strains of meningococcal bacteria. There was no significant difference in side effect profiles of the two vaccines, based on the data. for serogroup W to 20.5

Side effects 78

Side effects Medicine Safety Marketing 78

Pharmaceutical Technology

JUNE 12, 2023

However, side effects known as amyloid-related imaging abnormalities, which often involve brain swelling, were also reported, and consequently the treatment has a warning on this specific side effect on its label. The trial reported a statistically significant reduction of clinical decline in the patients.

Food and Drug Administration 52

Food and Drug Administration Side effects Prospecting FDA 52

PM360

MAY 25, 2023

adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 They’re wonderful medications, blockbuster sales, but real side effects. I think the best way is to come up with alternatives that don’t have these side effects, because then the problem is solved. million people.

Side effects 95

Side effects Medical Patients Networking 95

pharmaphorum

SEPTEMBER 7, 2022

The FDA had approved the drug for use as UC treatment in the US in May 2021. The recommended initial dosage is low, with a gradual build up in dosage, so as to reduce possible side effects such as upper respiratory infection, urinary tract infection, and hypertension.

Side effects 52

Side effects Patients FDA Medical 52

Pharmaceutical Technology

APRIL 21, 2023

Entadfi, a combination of finasteride and tadalafil, is administered as an oral, once-a-day drug to provide a safe and effective treatment option for benign prostatic hyperplasia (BPH), often referred to as enlarged prostate, in men. The US Food and Drug Administration granted approval to Entadfi for the treatment of BPH in December 2021.

Food and Drug Administration 52

Food and Drug Administration Side effects Distribution Sales 52

pharmaphorum

JANUARY 3, 2023

The new pivotal study in TRS will run in parallel to Newron’s ongoing phase 3 trial (Study 008A) of evenamide versus placebo over four weeks in patients with schizophrenia, which started in September 2021 and is due to generate results in the first half of this year.

Side effects 105

Side effects Biopharma Patients Competition 105

PM360

JULY 13, 2023

2021 revealed that roughly one in four prescriptions were never filled. 1 Patients may discontinue if they cannot afford their out-of-pocket costs even with insurance coverage due to side effects or lack of perceived need for the medication itself. Novartis’ analysis of claims data from Nov. 2020 to Oct.

Patients 98

Patients Side effects Insurance Medical 98

PM360

OCTOBER 24, 2022

While Urovant realized this, launching a new company, a new sales team, and a new therapy for OAB amidst the pandemic in early 2021 would be challenging. With all of this, GEMTESA was shown to be safe and tolerable—with only 2% of study participants discontinuing GEMTESA due to side effects.

Side effects 40

Side effects Doctors FDA Patients 40

Pharmaceutical Technology

MAY 26, 2023

The FDA first granted the drug under an emergency use authorisation (EUA) during the pandemic in December 2021. Paxlovid’s most common side effect is diarrhoea. It follows a March 2023 FDA Advisory Committee meeting where panelists voted 16-1 in favour of the drug’s approval.

Food and Drug Administration 59

Food and Drug Administration FDA Side effects Safety 59

PM360

JUNE 29, 2022

Despite a slew of prescription options and widespread advertising pushes, most patients are sticking with over-the-counter (OTC) remedies rather than trying new preventive medications, according to Phreesia Life Sciences’ survey results collected from more than 4,000 patients checking in for their doctors’ appointments in July 2021.

Prescription 98

Prescription Patients Pharma Doctors 98

European Pharmaceutical Review

JUNE 12, 2024

This randomised, open label-controlled multicentre clinical trial was conducted across 21 sites in Spain from 2021 to 2023. The specific representation of these events differed between the treatments, highlighting potential differences in side effect profiles that should be explored in further studies. 2021; 27 (2): S1-S21.

Safety 111

Safety Side effects Patients Healthcare 111

pharmaphorum

JULY 19, 2022

Steroids can be used to slow down progression of the condition, but can cause significant side effects if used too much and do nothing to restore the usual skin colour. Opzelura (ruxolitinib) is now the first alternative to steroid drugs for vitiligo, a chronic autoimmune disease that causes depigmentation of skin and affects around 1.5

FDA 95

FDA Side effects Sales Safety 95

Pharmaceutical Technology

AUGUST 17, 2022

In September 2021, the same study reported a 100% seroconversion rate after a booster was given to the participants. While there were concerns about Lymerix’s side effects, it was the low demand that led to its withdrawal, says Šíma, adding that VLA15 could be in a similar tough spot when it comes to its position on the market.

Side effects 119

Side effects Medicine Marketing Recruitment 119

LEVO Health

JULY 15, 2024

In 2021, the GLP-1 market was valued at $16.53 Educational Content Provide patients with comprehensive information about GLP-1 medications, their benefits, potential side effects, and how they work. billion and is projected to reach $24.10 billion by 2027. This can be done through blog posts, webinars, and informational videos.

Marketing 52

Marketing Side effects Education Medical 52

Pharmaceutical Technology

JULY 20, 2022

Prescribing it] requires knowledge of a patient’s medical history, as well as clinical monitoring for side effects and follow-up care to determine whether a patient is improving—requirements far beyond a pharmacist’s scope and training,” as per a statement by AMA president Jack Resneck.

Food and Drug Administration 111

Food and Drug Administration Physicians Medical Prescription 111

pharmaphorum

OCTOBER 27, 2022

It’s a disappointing outcome for a programme that GSK said in 2021 could potentially generate £1 to £2 billion in peak sales because of the serious unmet need in RA patients.

Side effects 80

Side effects FDA Patients Sales 80

pharmaphorum

JULY 19, 2022

China’s Simcere Pharmaceutical has been granted approval in its home market for Cosela, a drug designed to limit the side effects of cancer chemotherapy, partnered with US biotech G1 Therapeutics. The Chinese company secured rights to Cosela in Greater China for $170 million in 2020.

Side effects 59

Side effects Marketing Pharmaceutical Patients 59

pharmaphorum

JANUARY 26, 2023

The combination showed modest efficacy with an objective response rate of 25%, but was associated with considerable side effects that forced a change in dosing regimen. One glimmer of hope came from the CheckMate 650 trial of Bristol-Myers Squibb’s PD-1 drug Opdivo (nivolumab) and CTLA4 inhibitor Yervoy (ipilimumab).

Side effects 59

Side effects Patients FDA 59

Clarivate

JANUARY 3, 2023

Starting with 12,160 Research Fronts, representing papers published and cited between 2016 and 2021, the next step was to select the fronts containing core literature that is both highly cited and recent – an indicator of particularly active and fast-moving research.

Specialization 98

Specialization Side effects Management Medicine 98

PM360

AUGUST 9, 2022

Indeed, in research from the 2021 PURE Report, 3 50% of the patients responding found the therapy discussion to be a highly stressful period in their treatment journey. Start Patient Support Immediately. One of the most anxious times for patients is right after diagnosis when they are waiting to start treatment.

Education 59

Education Side effects Physicians Patients 59

pharmaphorum

DECEMBER 13, 2022

Krazati has been cleared as a treatment for patients with KRASG12C-mutated non-small cell lung cancer (NSCLC) after one prior systemic therapy – the same indication given to Amgen’s Lumakras (sotorasib) when it became the first KRAS inhibitor to be approved in the US in May 2021.

FDA 52

FDA Side effects Competition Patients 52

European Pharmaceutical Review

NOVEMBER 4, 2022

based treatment concomitant with reductions in traditionally unavoidable and problematic side effects. 2021 [cited 12 September 2022]. The importance of taxanes in oncology. Taxanes have played an important role in anticancer treatment for several decades. Volume 10, pp.1609–1621. 1609–1621. Oncology Nursing News. Karlovitch S.

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical FDA Patients 98

Pharmaceutical Technology

APRIL 13, 2023

Key opinion leaders (KOLs) interviewed by GlobalData highlighted the need for safer and more effective therapies with fewer side effects that would be suitable for the treatment of obesity, particularly for the management of weight loss following cessation of treatment.

Marketing 52

Marketing Side effects Physicians Management 52

European Pharmaceutical Review

OCTOBER 19, 2023

One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy. Hoppin served as lead director of Noria as the two organisations were sold to Bayer Healthcare in June of 2021.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Side effects Doctors 105

pharmaphorum

AUGUST 31, 2022

The treatment also has a 10-minute onset of action that, according to Future, is “demonstrably faster” than the orally-dosed active comparator (tadalafil) used in the study, and also avoids the potential side effects of oral drugs for ED, which can take 30-60 minutes to take effect.

FDA 52

FDA Side effects Medical Prescription 52

Contrarian Sales Techniques

FEBRUARY 26, 2023

According to Zion Market Research, the global generic market is growing at more than 10 percent per year and is expected to reach approximately $380 billion by 2021. This growth is reflected in improved public health and lower prices for consumers, as well as higher sales of generic medicines.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

European Pharmaceutical Review

JULY 5, 2022

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer.

Patients 104

Patients Food and Drug Administration Side effects Safety 104

LEVO Health

JUNE 14, 2024

Personalized Patient Communications A 2021 McKinsey report found that 76% of consumers find a lack of personalized messaging frustrating. For example, a patient wondering about their medication side effects at midnight can receive instant guidance from a virtual assistant.

Healthcare 52

Healthcare Healthcare Patients Healthcare Provider 52

pharmaphorum

SEPTEMBER 12, 2022

CodeBreak-200 will nevertheless likely serve as a confirmatory study for the approval of Lumakras (sotorasib) in this heavily pretreated patient population, which was granted by the FDA in May 2021.

Side effects 52

Side effects FDA Patients Safety 52

Pharmaceutical Technology

AUGUST 12, 2022

billion in 2021 and is forecast to reach $2.4 One key hematological indication in which CAR-T cells have been used as an effective therapeutic is diffuse large B-cell lymphoma (DLBCL), which occurs mostly in women. According to GlobalData’s Epidemiology database, there were 5,446 incident cases of DLBCL in the UK in 2021.

Side effects 52

Side effects Marketing Engineering Patients 52